| scholarly article | Q13442814 |
| P50 | author | Alexandre Harari | Q43779462 |
| Giuseppe Pantaleo | Q88061163 | ||
| P2093 | author name string | Florence Vallelian | |
| Pascal R Meylan | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1037-1045 | |
| P577 | publication date | 2005-01-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence. | |
| P478 | volume | 174 |
| Q61813267 | A Novel Vaccine Strategy Employing Serologically Different Chimpanzee Adenoviral Vectors for the Prevention of HIV-1 and HCV Coinfection |
| Q39441716 | A Recombinant Chimeric Ad5/3 Vector Expressing a Multistage Plasmodium Antigen Induces Protective Immunity in Mice Using Heterologous Prime-Boost Immunization Regimens |
| Q45415273 | A T2 cytokine environment may not limit T1 responses in human immunodeficiency virus patients with a favourable response to antiretroviral therapy |
| Q60321325 | A TGF-β mediated regulatory mechanism modulates the T cell immune response to rotavirus in adults but not in children |
| Q21135240 | A candidate HIV/AIDS vaccine (MVA-B) lacking vaccinia virus gene C6L enhances memory HIV-1-specific T-cell responses |
| Q36769107 | A dual color ELISPOT method for the simultaneous detection of IL-2 and IFN-gamma HIV-specific immune responses |
| Q35323147 | A lower viral set point but little immunological impact after early treatment during primary HIV infection |
| Q35015787 | A mycolic acid-specific CD1-restricted T cell population contributes to acute and memory immune responses in human tuberculosis infection |
| Q39906552 | A preliminary and comparative evaluation of a novel Ad5 [E1-, E2b-] recombinant-based vaccine used to induce cell mediated immune responses |
| Q39971299 | A soluble hexameric form of CD40 ligand activates human dendritic cells and augments memory T cell response |
| Q36673915 | Acutely dysregulated, chronically disabled by the enemy within: T-cell responses to HIV-1 infection. |
| Q38544976 | Adaptive Immunity in Schizophrenia: Functional Implications of T Cells in the Etiology, Course and Treatment |
| Q30375962 | Age at Mycobacterium bovis BCG Priming Has Limited Impact on Anti-Tuberculosis Immunity Boosted by Respiratory Mucosal AdHu5Ag85A Immunization in a Murine Model |
| Q42229225 | Age-associated Epstein-Barr virus-specific T cell responses in seropositive healthy adults. |
| Q84941487 | Alteration of CD8+ T cell effector diversity during HIV-1 infection with discordant normalization in effective antiretroviral therapy |
| Q51003363 | Altered T cell differentiation associated with loss of CD27 and CD28 in HIV infected Indian individuals. |
| Q36446900 | An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses |
| Q51835034 | Associations of serum EBV DNA and gammopathy with post-transplant lymphoproliferative disease. |
| Q34566311 | Attrition of T-cell functions and simultaneous upregulation of inhibitory markers correspond with the waning of BCG-induced protection against tuberculosis in mice |
| Q39707019 | Bacillus Calmette-Guérin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles |
| Q35101557 | CD127+CCR5+CD38+++ CD4+ Th1 effector cells are an early component of the primary immune response to vaccinia virus and precede development of interleukin-2+ memory CD4+ T cells |
| Q33988111 | CD4 and CD8 T-cell responses to mycobacterial antigens in African children |
| Q26824869 | CMV: Prevention, Diagnosis and Therapy |
| Q102056758 | COVID-19-Induced ARDS Is Associated with Decreased Frequency of Activated Memory/Effector T Cells Expressing CD11a+ |
| Q84295171 | Cellular immune parameters associated with spontaneous control of CMV in children who underwent transplantation |
| Q34142433 | Changes in function of HIV-specific T-cell responses with increasing time from infection |
| Q35784804 | Changes in paracrine interleukin-2 requirement, CCR7 expression, frequency, and cytokine secretion of human immunodeficiency virus-specific CD4+ T cells are a consequence of antigen load |
| Q34492399 | Characterisation of CD154+ T cells following ex vivo allergen stimulation illustrates distinct T cell responses to seasonal and perennial allergens in allergic and non-allergic individuals |
| Q33825748 | Chlamydia pneumoniae-induced memory CD4+ T-cell activation in human peripheral blood correlates with distinct antibody response patterns |
| Q33618094 | Data analysis in flow cytometry: the future just started |
| Q37684684 | Decreased memory T-cell response and function in human immunodeficiency virus-infected patients with tegumentary leishmaniasis. |
| Q34788477 | Defect in recruiting effector memory CD8+ T-cells in malignant pleural effusions compared to normal pleural fluid |
| Q37672921 | Definition of CD4 Immunosignatures Associated with MTB. |
| Q36447936 | Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing |
| Q37350429 | Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response |
| Q43920687 | Detection of polyfunctional Mycobacterium tuberculosis-specific T cells and association with viral load in HIV-1-infected persons |
| Q45233206 | Development and application of a multiplexable flow cytometry-based assay to quantify cell-mediated cytolysis |
| Q51031172 | Development of Cytomegalovirus and Adenovirus-Specific Memory CD4 T-Cell Functions From Birth to Adulthood |
| Q34117317 | Development of an antibody to bovine IL-2 reveals multifunctional CD4 T(EM) cells in cattle naturally infected with bovine tuberculosis |
| Q45368916 | Development of monoclonal antibodies (MAbs) to feline interferon (fIFN)-γ as tools to evaluate cellular immune responses to feline infectious peritonitis virus (FIPV). |
| Q42996799 | Differences in HCV-specific T cell responses between chronic HCV infection and HIV/HCV co-infection. |
| Q36082304 | Differences in antigen-specific CD4+ responses to opportunistic infections in HIV infection |
| Q41605285 | Differences in systemic adaptive immunity contribute to the 'frequent exacerbator' COPD phenotype |
| Q41748023 | Differential expression of THELPER 1 cytokines upon antigen stimulation predicts ex vivo proliferative potential and cytokine production of virus-specific T cells following re-stimulation. |
| Q51029588 | Distinct characteristics of seasonal (Bet v 1) vs. perennial (Der p 1/Der p 2) allergen-specific CD4(+) T cell responses. |
| Q34251332 | Distinct effector memory CD4+ T cell signatures in latent Mycobacterium tuberculosis infection, BCG vaccination and clinically resolved tuberculosis |
| Q39176024 | Distinct polyfunctional CD4+ T cell responses to BCG, ESAT-6 and CFP-10 in tuberculous pleurisy |
| Q37344826 | Dynamic relationship between IFN-gamma and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load |
| Q36315175 | Dynamics of T-cell responses and memory T cells during primary simian immunodeficiency virus infection in cynomolgus macaques |
| Q38208821 | Early Decision: Effector and Effector Memory T Cell Differentiation in Chronic Infection |
| Q35965247 | Effector Phenotype of Plasmodium falciparum-Specific CD4+ T Cells Is Influenced by Both Age and Transmission Intensity in Naturally Exposed Populations |
| Q36498151 | Efficient in vitro expansion of human immunodeficiency virus (HIV)-specific T-cell responses by gag mRNA-electroporated dendritic cells from treated and untreated HIV type 1-infected individuals |
| Q56994404 | Elite control of HIV infection: implications for vaccine design |
| Q55057118 | Emergence of CD4+ and CD8+ Polyfunctional T Cell Responses Against Immunodominant Lytic and Latent EBV Antigens in Children With Primary EBV Infection. |
| Q21135592 | Enumeration of functional T-cell subsets by fluorescence-immunospot defines signatures of pathogen burden in tuberculosis |
| Q41108399 | Epstein-Barr virus-specific CD8(+) T lymphocytes from diffuse large B cell lymphoma patients are functionally impaired. |
| Q33381644 | Fully immunocompetent CD8+ T lymphocytes are present in autologous haematopoietic stem cell transplantation recipients despite an ineffectual T-helper response |
| Q51976793 | Functional and phenotypic characterization of tetanus toxoid-specific human CD4+ T cells following re-immunization. |
| Q36452614 | Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases. |
| Q36529008 | Functional signatures of protective antiviral T-cell immunity in human virus infections. |
| Q36591344 | Generation and maintenance of human memory cells during viral infection. |
| Q34190681 | HIV controllers with HLA-DRB1*13 and HLA-DQB1*06 alleles have strong, polyfunctional mucosal CD4+ T-cell responses |
| Q37034594 | HIV-1-specific immune response. |
| Q33375075 | HLA Class I-T cell epitopes from trans-sialidase proteins reveal functionally distinct subsets of CD8+ T cells in chronic Chagas disease |
| Q36166161 | HSV-1 amplicon vectors elicit polyfunctional T cell responses to HIV-1 Env, and strongly boost responses to an adenovirus prime |
| Q40195846 | Helper function of cytolytic lymphocytes: switching roles in the immune response |
| Q36812029 | Heterogeneity among viral antigen-specific CD4+ T cells and their de novo recruitment during persistent polyomavirus infection |
| Q37807871 | High incidence of post transplant lymphoproliferative disorder after antithymocyte globulin-based conditioning and ineffective prediction by day 28 EBV-specific T lymphocyte counts |
| Q35806053 | Human CD4+ T Helper Cell Responses after Tick-Borne Encephalitis Vaccination and Infection |
| Q37807749 | Human cytomegalovirus immunity and immune evasion |
| Q36540073 | Human immunodeficiency virus viremia induces plasmacytoid dendritic cell activation in vivo and diminished alpha interferon production in vitro. |
| Q51980955 | Human memory T cell responses to SARS-CoV E protein. |
| Q45377997 | Human peripheral blood and bone marrow Epstein-Barr virus-specific T-cell repertoire in latent infection reveals distinct memory T-cell subsets |
| Q33997829 | IL-2 production correlates with effector cell differentiation in HIV-specific CD8+ T cells |
| Q30387865 | Identification of a CD4 T-cell epitope in the hemagglutinin stalk domain of pandemic H1N1 influenza virus and its antigen-driven TCR usage signature in BALB/c mice |
| Q37199493 | Immune activation and collateral damage in AIDS pathogenesis. |
| Q36688489 | Immune correlates of CD4 decline in HIV-infected patients experiencing virologic failure before undergoing treatment interruption |
| Q39982157 | Immune response and cytokine production following immunization with experimental herpes simplex virus 1 (HSV-1) vaccines. |
| Q36628376 | Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations |
| Q45411590 | Immunisation with recombinant modified vaccinia virus Ankara expressing HIV-1 gag in HIV-1-infected subjects stimulates broad functional CD4+ T cell responses |
| Q33427803 | Immunodominant HIV-1 Cd4+ T cell epitopes in chronic untreated clade C HIV-1 infection |
| Q27320923 | Immunogenic profiling in mice of a HIV/AIDS vaccine candidate (MVA-B) expressing four HIV-1 antigens and potentiation by specific gene deletions |
| Q36322944 | Immunologic memory in cutaneous leishmaniasis |
| Q63408431 | Immunological correlates of protection from HIV infection and disease |
| Q28469122 | Immunotherapy with canarypox vaccine and interleukin-2 for HIV-1 infection: termination of a randomized trial |
| Q34059488 | Impact of distinct poxvirus infections on the specificities and functionalities of CD4+ T cell responses |
| Q37159243 | Induction of alloanergy in human donor T cells without loss of pathogen or tumor immunity |
| Q34571341 | Infection of CD127+ (interleukin-7 receptor+) CD4+ cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infection |
| Q47738733 | Influence of antigen exposure on the loss of long-term memory to childhood vaccines in HIV-infected patients |
| Q36777844 | Interactions and management issues in HSV and HIV coinfection |
| Q50532589 | Interleukin-7 Unveils Pathogen-Specific T Cells by Enhancing Antigen-Recall Responses. |
| Q33911928 | Intrinsic functional dysregulation of CD4 T cells occurs rapidly following persistent viral infection |
| Q51982621 | Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients. |
| Q36641634 | Longitudinal changes in CD4(+) T-cell memory responses induced by BCG vaccination of newborns |
| Q37803335 | Management of cytomegalovirus infection in solid organ transplantation |
| Q35631642 | Maturation and Mip-1β Production of Cytomegalovirus-Specific T Cell Responses in Tanzanian Children, Adolescents and Adults: Impact by HIV and Mycobacterium tuberculosis Co-Infections |
| Q34605490 | Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells |
| Q37743265 | Modulation of HIV-1 virulence via the host glucocorticoid receptor: towards further understanding the molecular mechanisms of HIV-1 pathogenesis. |
| Q39527151 | Multiple functions of human T cells generated by experimental malaria challenge |
| Q35947812 | Multiple-cytokine-producing antiviral CD4 T cells are functionally superior to single-cytokine-producing cells |
| Q35562281 | NKG2D expression in CD4+ T lymphocytes as a marker of senescence in the aged immune system. |
| Q43125298 | Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination |
| Q35891526 | PD-1 Expression and Cytokine Secretion Profiles of Mycobacterium tuberculosis-Specific CD4+ T-Cell Subsets; Potential Correlates of Containment in HIV-TB Co-Infection |
| Q34592551 | PD-1 expression and IL-2 loss of cytomegalovirus- specific T cells correlates with viremia and reversible functional anergy |
| Q35947091 | Pathogen-specific T cell depletion and reactivation of opportunistic pathogens in HIV infection |
| Q51889236 | Patients with B cell chronic lymphocytic leukaemia have an expanded population of CD4 perforin expressing T cells enriched for human cytomegalovirus specificity and an effector-memory phenotype. |
| Q34241795 | Peripheral T cell cytokine responses for diagnosis of active tuberculosis |
| Q36246306 | Peripheral blood CD4 T-cell and plasmacytoid dendritic cell (pDC) reactivity to herpes simplex virus 2 and pDC number do not correlate with the clinical or virologic severity of recurrent genital herpes |
| Q34576202 | Phenotypic and functional profiling of CD4 T cell compartment in distinct populations of healthy adults with different antigenic exposure |
| Q42238387 | Phenotypic and transcriptional profile correlates with functional plasticity of antigen-specific CD4+ T cells. |
| Q34124001 | Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment |
| Q37349074 | Plasmodium falciparum apical membrane antigen 1 vaccine elicits multifunctional CD4 cytokine-producing and memory T cells |
| Q42982606 | Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication |
| Q36618086 | Polyfunctional T cell responses are a hallmark of HIV-2 infection |
| Q43739705 | Polyfunctional T cells in human tuberculosis |
| Q33557707 | Polyfunctional T lymphocytes are in the peripheral blood of donors naturally immune to coccidioidomycosis and are not induced by dendritic cells |
| Q46317692 | Polyfunctional cytomegalovirus-specific CD4+ and pp65 CD8+ T cells protect against high-level replication after liver transplantation |
| Q37287027 | Post-step modifications for research on HIV vaccines |
| Q92777098 | Potential of the dual IFN-γ/IL-2 fluorescence-immunospot assay to distinguish different stages in bovine tuberculosis |
| Q33826983 | Preclinical studies of a modified vaccinia virus Ankara-based HIV candidate vaccine: antigen presentation and antiviral effect |
| Q30418993 | Predominance of heterosubtypic IFN-γ-only-secreting effector memory T cells in pandemic H1N1 naive adults |
| Q36315197 | Preserved central memory and activated effector memory CD4+ T-cell subsets in human immunodeficiency virus controllers: an ANRS EP36 study |
| Q41718407 | Preserved immune functionality and high CMV-specific T-cell responses in HIV-infected individuals with poor CD4+ T-cell immune recovery |
| Q33769360 | Proliferation capacity and cytotoxic activity are mediated by functionally and phenotypically distinct virus-specific CD8 T cells defined by interleukin-7R{alpha} (CD127) and perforin expression |
| Q28742596 | Protective immunity induced with the RTS,S/AS vaccine is associated with IL-2 and TNF-α producing effector and central memory CD4 T cells |
| Q40393138 | Protein adsorption in microengraving immunoassays |
| Q36951735 | Public T cell receptors confer high-avidity CD4 responses to HIV controllers |
| Q58074723 | QuantiFERON®-CMV assay for the assessment of cytomegalovirus cell-mediated immunity |
| Q64374806 | Quantitative and Qualitative CD4 T Cell Immune Responses Related to Adenovirus DNAemia in Hematopoietic Stem Cell Transplantation |
| Q50862150 | Ratios of effector to central memory antigen-specific CD4(+) T cells vary with antigen exposure in HIV+ patients. |
| Q99239695 | Robust T cell response towards spike, membrane, and nucleocapsid SARS-CoV-2 proteins is not associated with recovery in critical COVID-19 patients |
| Q24647137 | Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa |
| Q44941905 | Screening and identification of T helper 1 and linear immunodominant antibody-binding epitopes in the spike 2 domain and the nucleocapsid protein of feline infectious peritonitis virus. |
| Q36022184 | Skewed association of polyfunctional antigen-specific CD8 T cell populations with HLA-B genotype |
| Q35077274 | Specific in vitro interferon-gamma and IL-2 production as biomarkers during treatment of chronic Q fever |
| Q51975009 | Spontaneous and vaccine induced AFP-specific T cell phenotypes in subjects with AFP-positive hepatocellular cancer. |
| Q36415780 | Studies of HIV-associated immune responses in lymphoid compartments |
| Q51988506 | Studies using a viral challenge and CD8 T cell depletions on the roles of cellular and humoral immunity in the control of an SHIV-89.6P challenge in DNA/MVA-vaccinated macaques. |
| Q36252595 | Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosis |
| Q33948002 | Systemic BCG immunization induces persistent lung mucosal multifunctional CD4 T(EM) cells which expand following virulent mycobacterial challenge |
| Q37382387 | T cell susceptibility to HIV influences outcome of opportunistic infections |
| Q37109528 | T-cell immunophenotyping distinguishes active from latent tuberculosis |
| Q37130458 | Tenets of protection from progression to AIDS: lessons from the immune responses to HIV-2 infection. |
| Q38725610 | The HIV/AIDS vaccine candidate MVA-B administered as a single immunogen in humans triggers robust, polyfunctional, and selective effector memory T cell responses to HIV-1 antigens. |
| Q36764394 | The Secreted Protein Rv1860 of Mycobacterium tuberculosis Stimulates Human Polyfunctional CD8+ T Cells |
| Q41665227 | The Significance of Discordant Serology in Chagas Disease: Enhanced T-Cell Immunity to Trypanosoma cruzi in Serodiscordant Subjects |
| Q46112690 | The adrenal steroid response during tuberculosis and its effects on the mycobacterial-driven IFN-gamma production of patients and their household contacts |
| Q24652185 | The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development? |
| Q39248903 | The microRNA-9/B-lymphocyte-induced maturation protein-1/IL-2 axis is differentially regulated in progressive HIV infection. |
| Q39527145 | The relationship between human effector and memory T cells measured by ex vivo and cultured ELISPOT following recent and distal priming |
| Q54249832 | The roles of resident, central and effector memory CD4 T-cells in protective immunity following infection or vaccination. |
| Q33591688 | Tuberculin skin testing and treatment modulates interferon-gamma release assay results for latent tuberculosis in migrants |
| Q36065998 | Tuberculosis Therapy Modifies the Cytokine Profile, Maturation State, and Expression of Inhibitory Molecules on Mycobacterium tuberculosis-Specific CD4+ T-Cells |
| Q36402838 | Unexpected prolonged presentation of influenza antigens promotes CD4 T cell memory generation |
| Q36802741 | Viral vector vaccines make memory T cells against malaria. |
| Q40602726 | When Aging Reaches CD4+ T-Cells: Phenotypic and Functional Changes |
| Q36787601 | c-Cbl expression levels regulate the functional responses of human central and effector memory CD4 T cells |
Search more.